Close

Savient Pharmaceuticals (SVNT) Posts Q4 Loss of 39c/Share

March 19, 2013 7:01 AM EDT Send to a Friend
Savient Pharmaceuticals (NASDAQ: SVNT) reported Q4 EPS of ($0.39), $0.05 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login